This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Academia Sinica. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations of Ching-Feng Chiu in Cancer Research
Introduction
Ching-Feng Chiu is a notable inventor based in Tainan, Taiwan. He has made significant contributions to cancer research, particularly in the area of cancer metastasis. His innovative work focuses on methods to suppress the spread of cancer cells, which is a critical challenge in cancer treatment.
Latest Patents
Ching-Feng Chiu holds a patent for the "Suppression of cancer metastasis." This patent outlines methods of using fibrillar proteins to inhibit cancer metastasis. The research indicates that tumor cell invasion and migration can be significantly reduced after treatment with fibrillar proteins such as rVP1, F-HSA, and F-BSA in vitro. Furthermore, rVP1 has shown promising results in significantly suppressing murine and human breast cancer metastasis, as well as human prostate and ovarian cancer metastasis in vivo. Additionally, F-HSA has been effective in significantly suppressing murine breast cancer metastasis.
Career Highlights
Ching-Feng Chiu is affiliated with Academia Sinica, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and patient outcomes. With a focus on innovative solutions, he continues to explore new avenues in cancer research.
Collaborations
Ching-Feng Chiu collaborates with esteemed colleagues, including Shu-Mei Liang and Shao-Wen Hung. Their combined expertise enhances the research efforts in the field of cancer metastasis.
Conclusion
Ching-Feng Chiu's innovative work in cancer research exemplifies the importance of scientific advancements in combating cancer metastasis. His contributions through patents and collaborations highlight the ongoing efforts to improve treatment outcomes for cancer patients.